Cytarabine is indicated in combination with other anti-cancer medications for the remission induction in acute non-lymphocytic leukemia of adult and pediatric patients. Also, the drug has clinical proved to be successful in treating acute nonlymphocytic leukemia and the blast stage of chronic myelocytic leukemia.
The dosage is decided by the doctor as this medication has to be given by someone else because it involves injecting the solution through a vein.
Warning & Precautions
Don't take the drug without consulting a doctor or physician .
Blood poisoning, sore throat, headache, dizziness, inflammation and serious allergic reactions.
Do not keep in reach of children. Do not refrigerate. Keep at
temperatures between 15° - 20°. The product should be used immediately
after opening the vial.
Every piece of information about the drug is intended to be general in nature. We neither claim any guarantee nor endorse any product or its manufacturer